CHF program will eventually succeed and help patients suffering from chronic cardiac failure around the world, imo. But its a niche market, not a massive money spinner.
I personally think management should wrap up negotiations with interested parties (assuming there is at least one!) and put their signatures on the dotted line for CHF program ASAP, even on less favourable terms than management would want. I am not asking management to give the program away like Teva did; they should try to achieve a win-win-win outcome for all shareholders, partnering pharma company and all potential patients who will benefit from mesoblast's years of research.
I have the impression that Prof Si is a tough negotiator and a shrewd businessman. But squeezing the last cent from your future partner on the negotiating table may hinder Mesoblast from moving forward into,
(God helps me, I am using Madam's words!), commercial sustainability. Cash flow from partnership will instantly help Mesoblast fund research on mesenchymal lineage stem cell (MLC) in Diabetes applications. I believe anti-inflammatory effects of MLC so far demonstrated are best suited to treat different inflammatory conditions (not just nephropathy) in Diabetes. If the research is shelved for cash flow reasons, our leading advantage will be eroded by other competitors. Both shareholders and diabetic patients will suffer in the end.
- Forums
- ASX - By Stock
- MSB
- Diabetes.......where are we at?
Diabetes.......where are we at?, page-4
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.31 |
Change
0.040(3.16%) |
Mkt cap ! $1.490B |
Open | High | Low | Value | Volume |
$1.28 | $1.32 | $1.26 | $3.433M | 2.652M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 39558 | $1.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.31 | 21776 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 39558 | 1.300 |
3 | 26433 | 1.295 |
6 | 108207 | 1.290 |
2 | 47468 | 1.285 |
3 | 10889 | 1.280 |
Price($) | Vol. | No. |
---|---|---|
1.310 | 21776 | 3 |
1.315 | 57441 | 5 |
1.320 | 2500 | 1 |
1.325 | 61160 | 4 |
1.330 | 15000 | 2 |
Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |